Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors.
Faes S, Planche A, Uldry E, Santoro T, Pythoud C, Stehle JC, Horlbeck J, Letovanec I, Riggi N, Datta D, Demartines N, Dormond O.
Faes S, et al. Among authors: uldry e.
Oncotarget. 2016 Jun 14;7(24):36666-36680. doi: 10.18632/oncotarget.9134.
Oncotarget. 2016.
PMID: 27153561
Free PMC article.